FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
-0.23%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$25.5B
AUM Growth
-$551M
(-2.1%)
Cap. Flow
+$201M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
35.92%
Holding
572
New
64
Increased
174
Reduced
183
Closed
94
Top Buys
| 1 |
Alibaba
BABA
|
$362M |
| 2 |
Fidelity National Information Services
FIS
|
$228M |
| 3 |
NXP Semiconductors
NXPI
|
$213M |
| 4 |
Apple
AAPL
|
$160M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
$132M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$191M |
| 2 |
Broadcom
AVGO
|
$187M |
| 3 |
Qualcomm
QCOM
|
$186M |
| 4 |
WP
Worldpay, Inc.
WP
|
$143M |
| 5 |
Citigroup
C
|
$138M |
Sector Composition
| 1 | Technology | 30.17% |
| 2 | Healthcare | 21.04% |
| 3 | Consumer Discretionary | 15.25% |
| 4 | Communication Services | 9.6% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Endava
DAVA
$553M
| $767K | ﹤0.01% |
20,254
-69,161
| -77% | -$2.62M |
|
|
BHVN
352
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $751K | ﹤0.01% |
18,000
-2,000
| -10% | -$83.4K |
|
353
Apellis Pharmaceuticals
APLS
$3.55B
| $747K | ﹤0.01% |
31,000
+28,000
| +933% | +$675K |
|
354
Protolabs
PRLB
$1.19B
| $746K | ﹤0.01% |
+7,309
| New | +$746K |
|
355
Afya
AFYA
$1.37B
| $737K | ﹤0.01% |
+28,753
| New | +$737K |
|
356
Fulcrum Therapeutics
FULC
$414M
| $711K | ﹤0.01% |
+107,138
| New | +$711K |
|
357
Twilio
TWLO
$16.7B
| $706K | ﹤0.01% |
6,421
-14,154
| -69% | -$1.56M |
|
358
Tetra Tech
TTEK
$9.48B
| $697K | ﹤0.01% |
40,175
| – | – |
|
359
Okta
OKTA
$16.1B
| $690K | ﹤0.01% |
7,008
-17,613
| -72% | -$1.73M |
|
360
Ascendis Pharma
ASND
$12.5B
| $674K | ﹤0.01% |
7,000
| – | – |
|
361
Valero Energy
VLO
$48.7B
| $653K | ﹤0.01% |
7,655
| – | – |
|
362
Fate Therapeutics
FATE
$116M
| $621K | ﹤0.01% |
40,000
+30,000
| +300% | +$466K |
|
363
DuPont de Nemours
DD
$32.6B
| $599K | ﹤0.01% |
8,403
-218
| -3% | -$15.5K |
|
364
Freshpet
FRPT
$2.7B
| $597K | ﹤0.01% |
12,000
| – | – |
|
365
Allegion
ALLE
$14.8B
| $580K | ﹤0.01% |
5,600
| – | – |
|
366
GeoPark
GPRK
$326M
| $579K | ﹤0.01% |
31,565
-11,394
| -27% | -$209K |
|
|
ARQL
367
DELISTED
Arqule Inc
ARQL
| $574K | ﹤0.01% |
80,000
| – | – |
|
|
IMMU
368
DELISTED
Immunomedics Inc
IMMU
| $570K | ﹤0.01% |
+43,000
| New | +$570K |
|
369
Penumbra
PEN
$11B
| $538K | ﹤0.01% |
+4,000
| New | +$538K |
|
370
American Express
AXP
$227B
| $520K | ﹤0.01% |
4,400
-600
| -12% | -$70.9K |
|
371
Woodward
WWD
$14.6B
| $519K | ﹤0.01% |
4,812
| – | – |
|
372
Gossamer Bio
GOSS
$668M
| $504K | ﹤0.01% |
30,000
-20,000
| -40% | -$336K |
|
373
MeiraGTx Holdings
MGTX
$619M
| $494K | ﹤0.01% |
31,000
+13,000
| +72% | +$207K |
|
374
BioMarin Pharmaceuticals
BMRN
$11.1B
| $455K | ﹤0.01% |
6,756
-13,247
| -66% | -$892K |
|
375
NMI Holdings
NMIH
$3.1B
| $402K | ﹤0.01% |
+15,300
| New | +$402K |
|